Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) saw a large decrease in short interest during the month of October. As of October 30th, there was short interest totaling 138,641 shares, a decrease of 89.7% from the October 15th total of 1,348,635 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 269,329 shares, the days-to-cover ratio is currently 0.5 days.
Analyst Ratings Changes
Separately, Barclays upgraded shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, November 3rd. Two analysts have rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Coloplast A/S currently has a consensus rating of “Moderate Buy”.
Check Out Our Latest Research Report on CLPBY
Coloplast A/S Trading Up 0.5%
Shares of OTCMKTS CLPBY traded up $0.04 during midday trading on Thursday, reaching $7.36. 4,473 shares of the stock were exchanged, compared to its average volume of 434,945. Coloplast A/S has a 12 month low of $5.64 and a 12 month high of $9.50. The company has a market capitalization of $16.59 billion, a price-to-earnings ratio of 35.05, a P/E/G ratio of 3.56 and a beta of 0.10. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94. The business has a 50-day simple moving average of $6.87 and a two-hundred day simple moving average of $6.77.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $0.09 EPS for the quarter, meeting analysts’ consensus estimates of $0.09. The business had revenue of $1.12 billion during the quarter, compared to analysts’ expectations of $1.12 billion. Coloplast A/S had a net margin of 10.57% and a return on equity of 42.25%. As a group, equities research analysts expect that Coloplast A/S will post 0.37 EPS for the current year.
About Coloplast A/S
Coloplast A/S is a Danish medical device company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and urology care. Its products include ostomy bags and accessories, catheters and other continence products, wound dressings, and devices used in urological procedures. Coloplast also provides voice and respiratory care products, including solutions for people who have had a laryngectomy.
See Also
- Five stocks we like better than Coloplast A/S
- Tesla’s Plan to End Cybertruck Reveals Its Real Priorities
- The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
